Keywords: ec, approves, sebivo, chronic, hbv, european, commission

EC approves Sebivo for chronic HBV

Article | 07 May 2007

Print This

The European Commission has approved Sebivo (telbivudine), a new once-a-day pill for adult patients with chronic hepatitis B (CHB) with ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in